subscribe
 

Novartis receives positive CHMP opinion for Ilaris®

Novartis receives positive CHMP opinion for Ilaris® in active Systemic Juvenile Idiopathic Arthritis, a serious form of childhood arthritis.

Cheaper anti-cancer drug as effective as expensive drug in treating most common cause of blindness in older adults

An anti-cancer drug has been proven to be equally as effective in treating the most common cause of blindness in older adults as a more expensive drug specifically formulated for this purpose.

Roche launches new ProGRP test for more precise diagnosis in lung cancer

New test expands cancer diagnostics portfolio and strengthens Roche Diagnostics’ comprehensive tumour marker menu.

Galen acquires Synera® (lidocaine 70mg/tetracaine 70mg) topical patch

Galen, a Northern Ireland based pharmaceutical company, has acquired Synera® (lidocaine 70mg/tetracaine 70mg) topical patch from ZARS Pharma Inc., a wholly owned subsidiary of Nuvo Research Inc.

Roche halts investigation of aleglitazar

Roche has announced that following the results of a regular safety review of the aleglitazar AleCardio phase III trial, the independent Data and Safety Monitoring Board (DSMB) has recommended to halt the trial due to safety signals and lack...

Technological breakthrough paves the way for better drugs

Researchers at Karolinska Institutet in Sweden have developed the first method for directly measuring the extent to which drugs reach their targets in the cell.

Staphylococcus aureus vaccine

A consortium comprising Imaxio, the Jenner Institute at Oxford University, the European Vaccine Initiative and Preclin Biosystems has been awarded a major FP7 grant to support development and phase I clinical trial of an S. aureus vaccine.

Victrix CMCC chooses Cresset’s software for drug discovery consulting projects

Under a new agreement, Victrix CMCC will use Cresset’s software for their computational chemistry consulting projects.

3D spheroid assays for cancer drug screening

AMSBIO has introduced a new range of 96-well format 3D Spheroid Cell Proliferation / Viability Assays, providing a new tool to allow...

Clot-buster trial reveals long-term benefits for stroke patients

Patients given a clot-busting drug within six hours of a stroke are more likely to have a long-lasting recovery than those who do not receive the treatment, new research has found.

Public to see impact of medical research funding

Europe’s largest store of open-access biomedical literature has joined forces with a leading online research outcomes system to connect research articles and grants with data on their impact.

‘Next generation’ cancer drug shows promise in early trial

A new potential cancer drug has shown promising results in an early stage clinical trial. The drug, called AUY922, could help lead to a new way to treat a wide range of cancers including breast and lung cancer.

Cobra Biologics and Novolytics unveil successful development of bacteriophages against bacterial infection

Cobra Biologics and Novolytics have announced a breakthrough in the development of two Staphylococcus aureus based phage products for Phase I clinical trials with a 100 fold increase in upstream process yields.

Plasticell Ltd and Progenitor Labs join thriving community at SBC

Stevenage Bioscience Catalyst (SBC), the UK’s first open innovation bioscience campus, is pleased to welcome regenerative medicine companies Plasticell Ltd and Progenitor Labs as tenants.

Roche's RoACTEMRA approved in EU to treat children with rare form of arthritis

Roche has announced that the European Medicines Agency has approved RoACTEMRA to treat children with polyarticular juvenile idiopathic arthritis (PJIA), a rare, chronic and debilitating form of childhood arthritis.

Researchers reveal malaria's deadly grip

International researchers have identified how malaria parasites growing inside red blood cells stick to the sides of blood vessels in severe...

Curie-Cancer and Biolog-id sign partnership agreement

Within the partnership, Curie-Cancer and Biolog-id will develop a pilot system of RFID tags suitable for use in tracking cancer chemotherapy preparations

Sub-Visible Particles: impact on therapeutic proteins

SP Scientific has announced a new LyoLearn webinar, due to run on 27th June 2013, entitled 'Sub-visible Particles: Impacts on Aggregation...

Arthritis Research UK - Promoting effective and efficient reporting

In a world increasingly focused on accountability, over 30 leading research funding organisations including Arthritis Research UK have joined forces to use a new research outcomes reporting system called Researchfish.

Patients at risk of heart disease set to benefit from clinical trial

Patients suffering from high blood pressure - the single most important risk for death worldwide - could be helped by a UK-wide clinical trial aimed at improving treatments.

Pages

Newsbrief

Twitter Icon © Setform Limited
subscribe